---
figid: PMC10558228__ijmm-52-5-05314-g01
figtitle: MAPK signaling pathway and targets of inhibitors against neuroinflammation
  in AD
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10558228
filename: PMC10558228__ijmm-52-5-05314-g01.jpg
figlink: /pmc/articles/PMC10558228/figure/F2
number: F2
caption: MAPK signaling pathway and targets of inhibitors against neuroinflammation
  in AD. AD, Alzheimer's disease; 1, MW01-2-069A-SRM; 2, MW181; 3, MMI-0100; 4, methanol
  extracts of Piper sarmentosum roots; 5, EGB761; 6, cryptolepine; 7, VB-037; 8, dexmedetomidine;
  9, Hominis placenta; 10. BJe; 11, diammonium glycyrrhizinate; 12, tripterygium glycosides;
  13, LX007; 14, pseudane-VII; 15, sorbinil and zopolrestat; 16, Artemisiae Iwayomogii
  Herba; 17, tectorigenin; 18, circumdatin D; 19, 1-O-acetylbritannilactone; 20, Ganoderma
  lucidum extract GLE; 21, Atractylodis Rhizoma Alba ethanolic extract; 22, ulmoidol;
  Aβ, amyloid β; LPS, lipopolysaccharide; TLRs, Toll-like receptors; MyD88, myeloid
  differentiation factor 88; IKK, IκB kinase; JNK, c-Jun NH2-terminal kinases; MK2,
  MAPK-activated protein kinase II; AP-1, activator protein 1.
papertitle: Inflammatory signaling pathways in the treatment of Alzheimer's disease
  with inhibitors, natural products and metabolites (Review)
reftext: Yujia Zheng, et al. Int J Mol Med. 2023 Nov;52(5).
year: '2023'
doi: 10.3892/ijmm.2023.5314
journal_title: International Journal of Molecular Medicine
journal_nlm_ta: Int J Mol Med
publisher_name: D.A. Spandidos
keywords: Alzheimer's disease | neuroinflammation | inhibitor | inflammatory signaling
  pathways | treatment
automl_pathway: 0.8800997
figid_alias: PMC10558228__F2
figtype: Figure
redirect_from: /figures/PMC10558228__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10558228__ijmm-52-5-05314-g01.html
  '@type': Dataset
  description: MAPK signaling pathway and targets of inhibitors against neuroinflammation
    in AD. AD, Alzheimer's disease; 1, MW01-2-069A-SRM; 2, MW181; 3, MMI-0100; 4,
    methanol extracts of Piper sarmentosum roots; 5, EGB761; 6, cryptolepine; 7, VB-037;
    8, dexmedetomidine; 9, Hominis placenta; 10. BJe; 11, diammonium glycyrrhizinate;
    12, tripterygium glycosides; 13, LX007; 14, pseudane-VII; 15, sorbinil and zopolrestat;
    16, Artemisiae Iwayomogii Herba; 17, tectorigenin; 18, circumdatin D; 19, 1-O-acetylbritannilactone;
    20, Ganoderma lucidum extract GLE; 21, Atractylodis Rhizoma Alba ethanolic extract;
    22, ulmoidol; Aβ, amyloid β; LPS, lipopolysaccharide; TLRs, Toll-like receptors;
    MyD88, myeloid differentiation factor 88; IKK, IκB kinase; JNK, c-Jun NH2-terminal
    kinases; MK2, MAPK-activated protein kinase II; AP-1, activator protein 1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRF6
  - MYD88
  - TLR4
  - NFKB1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - KCNA2
  - MAPKAPK2
  - PTGS2
  - IL1A
  - IL1B
  - NOS2
  - ISYNA1
  - TNF
  - IL6
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - LPS
  - Nucleus
---
